Notice regarding the difference between actual results and the forecast for the consolidated results for the second quarter of the fiscal year ending December 2026, and revisions to the full-year consolidated earnings forecast

Earnings overview

For the second quarter of the fiscal year ending December 2026, net sales were broadly in line with the prior forecast, while operating income, ordinary income, and net income attributable to owners of the parent on a actual results basis exceeded the previous forecast. Factors include increased real estate rents, earlier completion of repairs, strong performance in the textile segment, and cost reductions in the pharmaceutical business. Based on this, the full-year forecast has been revised upward. The reason cited for the revision includes the postponement of a portion of repairs to the third quarter onward.

Outlook and impact

This year's full-year outlook projects sales to be the same as the prior forecast, while operating income, ordinary income, and net income attributable to owners of the parent are expected to rise. Stable growth in textiles, real estate, and pharmaceuticals, along with effective cost management, is expected to improve profitability. Future risks include potential delays in repair plans from the third quarter onward and other market developments that could alter actual results.